DOCUSIGN, INC. (DOCU): what the price assumes

In the published model solve dated 2026-Q2, anchored at $68.40, DOCUSIGN, INC. (DOCU) is priced for today's economics sustained for ~12.8 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/DOCU

Headline

FieldValue
TickerDOCU
CompanyDOCUSIGN, INC.
Sector / IndustryTechnology
Current price$68.40/sh
CompositionSubscription 98% / Professional services and other 2%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)8.8%
Operating margin today12.0%
Margin compression (value-band)-3.2pp
Must persist for12.8y
Multiple paid31x operating income

The operating-margin figure is value-band context at year 8: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 12.6% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: n/a

ReferenceValue
cohort percentile (of 190 peers)55

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.58x5expensive
Earnings1.97x5expensive
Relative0.99x5justifies
Growth0.72x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.9%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$159.170.43xyesFCF base $1.3B, growth 9% (input: historical growth), terminal g 4.0%, WACC 8.9%, 6yr projection
DCF Exit MultipleGrowth$95.370.72xyesExit EV/EBITDA: 22.2x / 24.2x / 26.2x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$68.910.99xyesP/E 35x (static sector reference · 2026-04), scenarios: 29.1x / 35.0x / 40.9x (bear / base = reference held flat / bull), EV/EBITDA 25x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$19.083.58xyesBV/sh $9.19, ROE (TTM) 19.2%, ke 9.3%
Two-Stage Excess ReturnAsset$27.182.52xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$57.931.18xyesRev $3.4B, growth 9% (input: historical growth; tapered), Terminal P/S: 3.2x / 3.8x / 4.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$43.681.57xyesEPS $1.64, growth 27% (input: historical EPS growth), PEG=1.45 (Fair)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$5.8511.69xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.15B × (1−38%) / WACC 8.9% → EPV (no growth)
Residual IncomeAsset$26.592.57xyesBV $9.19 + 5yr PV of (ROE (TTM) 19.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$18.423.71xyes√(22.5 × EPS $1.64 × BVPS $9.19) — Graham's conservative floor
EV/EBITDA RelativeRelative$70.620.97xyesEBITDA $0.52B × sector EV/EBITDA 25.0x
FCF YieldEarnings$69.720.98xyesFCF $1198.3M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$34.661.97xyesSBC-adj FCF $0.59B (FCF $1.20B − SBC $0.61B) capitalized at Kₑ
Ben Graham FormulaEarnings$52.921.29xyesEPS $1.64 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$4.5814.93xyesBV $9.19 × (ROIC 4.5% / WACC 8.9%)
P/Sales SectorRelative$143.870.48xyesRevenue $3.36B × sector P/S 8.0x
PEG Fair ValueRelative$61.501.11xyesEPS $1.64 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$17.733.86xyesEPS $1.64 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$777.7m
Net debt / NOPAT (after-tax)-3.11x (net cash)
Net debt / operating income (pre-tax)-1.93x (net cash)
Interest coverage170.4x
Share count CAGR (buyback)-0.9%
Burning cashno

Bullet Takeaways

Bull Case

Docusign has stopped being a growth company, and the numbers make far more sense once that is said out loud. Revenue in the quarter ended April 30, 2026 was 830.2 million dollars, up 9% year over year with roughly 1.6 points of that from currency. A mature software business is not judged on the growth line. It is judged on how much cash it produces and what it does with that cash, and on that test this quarter was straightforwardly good: free cash flow of 289.4 million dollars against 227.8 million a year earlier, and 317.5 million dollars of stock bought back in the same three months.

The effect of that buyback is not cosmetic. Diluted weighted-average shares fell to 196 million from 213 million over the year, and management's guidance for the fiscal year ending January 31, 2027 puts non-GAAP diluted shares at 190 million to 195 million. Retiring roughly eight percent of the shares in twelve months means per-share results grow meaningfully faster than the business does, which is the arithmetic that makes a single-digit grower work for a holder.

What funds that is a product that is genuinely difficult to displace at the workflow level. Docusign's platform now runs inside the systems its customers already use, with integrations named in the quarter across Coupa, Microsoft Copilot, Salesforce, SAP and Slack, and an open Model Context Protocol server connecting it to frontier models including Anthropic Claude, Gemini and OpenAI ChatGPT, on a GAAP gross margin of 79.4% for the quarter. Once an agreement process is wired into a company's CRM and procurement system, moving it is not a purchasing decision. It is a project.

The transition to the newer platform is also measurable rather than aspirational, which is unusual at this stage of a software company's life. Intelligent Agreement Management accounted for 12.6% of total annual recurring revenue as of April 30, 2026, up from 10.8% as of January 31, 2026, with 40,000 customers on it. The company describes the strategic logic in its own filing: Now, with our IAM platform, the insights that are unlocked from agreement data represent a significant opportunity for our customers. By expanding within an organization, we believe we can generate incremental revenue through the addition of new users, seat expansions and higher spend. Nearly two points of recurring revenue mix shifting in a single quarter is a faster migration than most platform transitions manage.

Profitability guidance backs the same story. For the year ending January 31, 2027 the company guides a non-GAAP operating margin of 30.5% to 31.0% and revenue of 3,490 million to 3,502 million dollars, alongside recurring revenue growth of 8.25% to 8.75%. The honest objection is that the gap between those margins and the GAAP ones is stock paid to employees, which is a real cost. It is a real cost that is currently being neutralised in the share count rather than allowed to accumulate, which is more than most software companies at this margin level can say.

Bear Case

The variable with the most leverage over this business is not a software budget. It is how many things are being bought, sold, hired and financed across the wider economy. Docusign is paid, in the end, per agreement, and its own filing makes the connection plainly when explaining its unit of sale: For several use cases, such as buying a home, multiple Envelopes are used over the course of the process. Mortgage volume, hiring, procurement and deal-making all move with interest rates, and the risk factors return to that exposure repeatedly, naming macro-economic factors, including inflation, changes in interest rates, government shutdowns, or reductions in the government workforce. A price that reads this company as a subscription line is not pricing the transaction cycle underneath it.

The reported growth also flatters the underlying pace. The 9% increase in the quarter included approximately 1.6 points of positive currency effect, and the company states that its own full-year guidance range would be roughly 1.3 points lower excluding currency. Strip that out and the business is compounding at closer to seven and a half percent. Currency tailwinds are borrowed, not earned, and they reverse.

Then there is the awkward fact that the technology powering the growth story is also the technology most likely to erode the moat, and the company says so itself: As AI advances make some foundational capabilities for agreements (such as analyzing, summarizing, comparing, and acting upon text) cheaper and easier to replicate, our eSignature and Intelligent Agreement Management platform may also increasingly compete with providers of LLMs, data platform companies and other enterprise software companies, and with homegrown solutions developed internally by customers. That is the incumbent naming its own commoditisation risk in a filing, which is not a thing companies do lightly.

The competitive comparison is not favourable either. The 10-K states that Our primary global competitor for eSignature is currently Adobe, which offers an electronic signature solution known as Adobe Acrobat Sign. ADBE carries 25.2 billion dollars of revenue growing 11.5%, at an operating margin of 36.1%, and it can bundle signature capability into a document suite that is already installed. Competing with a bundled feature is a structurally worse position than competing with a product, because the customer never has to make a separate decision to switch.

Finally, the profitability question. The company earned an operating margin of about 10% over the trailing year on the reported income statement, while guiding to a non-GAAP operating margin of 30.5% to 31.0% for the year ahead. The bridge is stock-based compensation, and it is large. This matters because the price is underwriting operating profit compounding at close to the fastest pace the business could fund out of its own cash flow, and sustaining it far longer than most businesses manage; only about 15% of comparable fast growers held such a pace across a full decade. Management, meanwhile, is guiding recurring revenue growth of 8.25% to 8.75% for the current fiscal year. Those two statements are difficult to hold at the same time.

Valuation

Two versions of this company's cash flow exist, and everything else follows from which one you use. Reported free cash flow was 289.4 million dollars in the quarter ended April 30, 2026, and cash from operations for the full prior fiscal year was 1.2 billion dollars. Both figures add back stock-based compensation, because that expense is settled in shares rather than money. Capitalise the reported figure and today's price looks undemanding; capitalise the version that treats employee stock as the cost it economically is, and the price looks roughly twice as expensive. The methods in this report split along exactly that line, and neither side of the split is a mistake.

Set against the price, the pattern is legible. The peer-multiple approaches and the forward-growth approaches both land above where the stock trades, which is what you would expect for a business the market has already de-rated. Running the other way, the price sits well above where the asset-value methods center, at close to three times their reading, and more than twice where the earnings-power methods land. Those two families are the ones that credit no future growth at all. The disagreement is not really about Docusign's business; it is about whether growth at the current pace deserves to be capitalised.

The requirement embedded in the price is where that becomes concrete. Today's price assumes operating profit compounds close to the fastest rate this business could fund from its own cash flow, and keeps doing it for well over a decade. Historically only about 15% of comparable fast growers sustained such a pace across a full decade. Against that, management guides revenue of 3,490 million to 3,502 million dollars for the year ending January 31, 2027 and recurring revenue growth of 8.25% to 8.75%. The gap between what the price needs and what the company is forecasting is the whole valuation question, and it does not require a view on the technology to see.

The peer group puts the profitability in context rather than the multiple. ADBE runs an operating margin of 36.1% on 25.2 billion dollars of revenue growing 11.5%. MANH runs 25.6% on 1.1 billion dollars growing 4.8%, and DBX runs 26.8% on 2.53 billion dollars with revenue slightly down. Docusign's roughly 10% reported operating margin sits beneath all three, on growth that beats only DBX and MANH. On the non-GAAP basis the company prefers, that ordering changes completely, which is another way of saying the entire comparison turns on how stock compensation is treated.

The balance sheet removes the tail risk from all of this. Cash, cash equivalents and investments stood at 1.0 billion dollars at April 30, 2026, and the company spent 317.5 million dollars repurchasing stock in that quarter alone. A business generating this much cash with that behind it is not going to be forced into anything. What the balance sheet cannot settle is whether buying back shares at today's price is the best available use of the money, and that answer depends entirely on which of the two free cash flow figures turns out to be the real one.

Catalysts

First-quarter fiscal 2027 results were reported on June 4, 2026, and they set out the year's arithmetic clearly. Revenue of 830.2 million dollars grew 9%, free cash flow reached 289.4 million dollars, and the company repurchased 317.5 million dollars of stock, which it described as a record. Intelligent Agreement Management reached 12.6% of total annual recurring revenue, from 10.8% three months earlier, with 40,000 customers on the platform. That mix figure is the single most informative number the company publishes each quarter, because it measures whether the newer product is replacing the older one fast enough to matter.

Guidance gives the next two reporting dates something specific to be measured against. For the quarter ending July 31, 2026 the company guides revenue of 865 million to 869 million dollars, and for the year ending January 31, 2027, revenue of 3,490 million to 3,502 million dollars with annual recurring revenue growth of 8.25% to 8.75% and a non-GAAP operating margin of 30.5% to 31.0%. Non-GAAP diluted share count is guided to 190 million to 195 million, so the buyback is expected to keep shrinking the base through the year.

The product calendar has already delivered its main event for the year. At the Momentum conference in May 2026 the company introduced new capabilities built on Iris, its agreement AI engine, including agents that check contracts against internal standards and request approvals, background monitoring that flags risks and obligations, and Agent Studio for building custom workflow agents. Alongside those came partnerships with legal AI platforms including Harvey, Legora and CoCounsel by Thomson Reuters. None of that shows up in revenue yet. Where it will show up first, if it works, is in the recurring revenue mix figure.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Docusign Q1 fiscal 2027 results, June 4, 2026

View the full interactive DOCU report on boothcheck